NCT02965950View on ClinicalTrials.gov

The p53 Breast Cancer Trial

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2033

Conditions
Locally Advanced Breast CancerMetastatic Breast Carcinoma
Interventions
DRUG

Cyclophosphamide

I.v. infusion

Trial Locations (5)

5021

Haukeland University Hospital, Bergen

Unknown

St. Olavs Hospital, Trondheim

Akershus University Hospital, Lørenskog

Stavanger University Hospital, Stavanger

University Hospital of Northern Norway, Tromsø

All Listed Sponsors
lead

Haukeland University Hospital

OTHER